The partnership between Neupharma and PARI can certainly be considered the perfect synthesis of a pharmaceutical company dedicated to the treatment of cystic fibrosis and a company specialized in the study, development and production of high-tech medical devices for respiratory therapy.
PARI has its roots back in 1906 in Germany. In 1984, it launched the first aerosol therapy device and moved all production sites and laboratories to the Starnberg district.
It was almost inevitable that Neupharma became the exclusive distributor for Italy of all medical devices and drugs developed by PARI in 2014. This consolidated a relationship based on the excellence of the therapeutic offer, efficacy and speedy response to requests from healthcare professionals and patients.